VP - Oncology Clinical Development - Lung and Head/Neck Cancers - London

Job summary

Are you a pharmaceutical oncology clinical development leader keen to unite science, technology and talent to get ahead of disease together in a company with an emerging portfolio seeking to make transformative breakthroughs? If so, this VP level career opportunity at GSK is worth consideration.

Responsibilities

• Accountable for the end-to-end clinical development of a portfolio clinical assets from first-time in human (FTIH) clinical trials through proof-of-concept (POC) studies, and registrational trials, to regulatory approval and initial market launch
• Accountable for ensuring medical, clinical and disease area knowledge is integrated into pre-clinical research activities (e.g. prior to candidate selection)
• Lead and drive development of a given oncology disease area knowledge and expertise, aligning and liaising across R&D, medical affairs and commercial functions; co-leading the Lung Oncology Tumor Team (e.g. disease area strategy team)
• Accountable for leading R&D focused scientific advisory boards to position individual assets and portfolio of assets in a specific disease area for success in a highly competitive environment

Qualifications

• Medical degree and a clinical medical specialty qualification/registration in Internal Medicine, Medical Oncology (adult or peds), Hematology or Pathology
• Direct line management experience of oncology clinical development teams as well as matrix management experience
• Pharmaceutical experience in early and late phase Oncology drug development
• Experience with clinical and translational investigation of Oncology agents in lung and head/neck cancers
• Experience successfully developing and executing oncology Clinical Development Plans

Job description